Purchases and Sales Made in Q1 2025 in Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL) during Q1 2025. The information is specifically focused on institutions that hold shares of Zentalis Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 09, 2025
Q1 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-462K- 50.29% |
$734K - $1.5M
|
456K
$653K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-619K- 36.14% |
$985K - $2.01M
|
1.09M
$1.56M
|
|
|
May 14, 2025
Q1 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-910K- 92.89% |
$1.45M - $2.95M
|
69.7K
$99.6K
|
|
|
May 15, 2025
Q1 2025
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-1.09M- 89.95% |
$1.74M - $3.55M
|
122K
$175K
|
|
|
May 15, 2025
Q1 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-3.15M- 97.79% |
$5M - $10.2M
|
71.1K
$102K
|